Biogen (BIIB) Current Assets (2016 - 2025)
Historic Current Assets for Biogen (BIIB) over the last 17 years, with Q4 2025 value amounting to $9.0 billion.
- Biogen's Current Assets rose 2034.79% to $9.0 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.0 billion, marking a year-over-year increase of 2034.79%. This contributed to the annual value of $9.0 billion for FY2025, which is 2034.79% up from last year.
- According to the latest figures from Q4 2025, Biogen's Current Assets is $9.0 billion, which was up 2034.79% from $8.9 billion recorded in Q3 2025.
- Biogen's 5-year Current Assets high stood at $10.4 billion for Q2 2023, and its period low was $6.7 billion during Q1 2021.
- Moreover, its 5-year median value for Current Assets was $7.9 billion (2021), whereas its average is $8.2 billion.
- In the last 5 years, Biogen's Current Assets skyrocketed by 3635.01% in 2022 and then crashed by 3185.67% in 2024.
- Biogen's Current Assets (Quarter) stood at $7.9 billion in 2021, then grew by 24.63% to $9.8 billion in 2022, then dropped by 29.94% to $6.9 billion in 2023, then rose by 8.71% to $7.5 billion in 2024, then rose by 20.35% to $9.0 billion in 2025.
- Its Current Assets was $9.0 billion in Q4 2025, compared to $8.9 billion in Q3 2025 and $8.0 billion in Q2 2025.